Emerging approaches to induce immune tolerance to therapeutic proteins.

Noel, Justine C; Lagassé, Daniel; Golding, Basil; Sauna, Zuben E

Noel, Justine C; Lagassé, Daniel; Golding, Basil; Sauna, Zuben E.

Afiliación

Noel JC; Division of Hemostasis, Office of Plasma Protein Therapeutics, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Lagassé D; Division of Hemostasis, Office of Plasma Protein Therapeutics, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Golding B; Division of Plasma Derivatives, Office of Plasma Protein Therapeutics, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Sauna ZE; Division of Hemostasis, Office of Plasma Protein Therapeutics, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: zuben.sauna@fda.hhs.gov.

Trends Pharmacol Sci ; 44(12): 1028-1042, 2023 12.

Article en En | MEDLINE | ID: mdl-37903706

Asunto(s)

Tolerancia Inmunológica; Factores Inmunológicos; Humanos; Edición Génica

Palabras clave

antidrug antibodies; immune tolerance; immunogenicity; protein therapeutics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tolerancia Inmunológica / Factores Inmunológicos Límite: Humans Idioma: En Revista: Trends Pharmacol Sci Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google